Filtered By:
Countries: France Health

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 151 results found since Jan 2013.

From Surgeries To Keeping Company: The Place Of Robots In Healthcare
Assisting surgeries, disinfecting rooms, dispensing medication, keeping company: believe it or not these are the tasks medical robots will soon undertake in hospitals, pharmacies, or your nearest doctor’s office. These new ‘colleagues’ will definitely make a difference in every field of medicine. Here’s our overview to understand robotics in healthcare better so that everyone can prepare for the appearance of mechanic helpers in medical facilities. Metallic allies for the benefit of the vulnerable While there are concerns for machines replacing people in the workforce, we believe there are adv...
Source: The Medical Futurist - October 8, 2019 Category: Information Technology Authors: berci.mesko Tags: Future of Medicine Future of Pharma Robotics blood digital health future of hospital Healthcare medical medical robot nanorobot nanotechnology pharmacies social social companion social companion robot Surgery telemedical Source Type: blogs

Study supports benefit of statin use for older adults
In this study, the most common reason that patients or their doctors stopped statins was the development of advanced cancer or other major illness. In my practice, I have also cared for many patients who have stopped taking statins or who express reluctance to take statins due to side effects. The most common side effect is muscle ache (typically tenderness or soreness of the large muscle groups, such as the biceps and thighs), which affects about 20% of statin takers and reverses when the statin is discontinued. There is also a slightly increased risk of diabetes with long-term statin use and, very rarely, liver problems....
Source: Harvard Health Blog - October 2, 2019 Category: Consumer Health News Authors: Dara K. Lee Lewis, MD Tags: Drugs and Supplements Health Healthy Aging Heart Health Source Type: blogs

Popular heartburn drug ranitidine recalled: What you need to know and do
If you or a family member take ranitidine (Zantac) to relieve heartburn, you may have heard that the FDA has found a probable human carcinogen (a substance that could cause cancer) in it. The story is unfolding quickly and many details remain murky. Here is what we know so far and what you should do. What do we know so far? On September 13, 2019, the FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication used by millions of Americans. This week, the drug companies Novartis (through its generic division, Sandoz) and Apotex announced that they were recalli...
Source: Harvard Health Blog - September 28, 2019 Category: Consumer Health News Authors: Joshua Gagne, PharmD, ScD Tags: Digestive Disorders Drugs and Supplements Health Source Type: blogs

Popular heartburn drug ranitidine (Zantac) recalled: What you need to know and do
If you or a family member take ranitidine (Zantac) to relieve heartburn, you may have heard that the FDA has found a probable human carcinogen (a substance that could cause cancer) in it. The story is unfolding quickly and many details remain murky. Here is what we know so far and what you should do. What do we know so far? On September 13, 2019, the FDA announced that preliminary tests found low levels of N-nitrosodimethylamine (NDMA) in ranitidine, a heartburn medication used by millions of Americans. This week, the drug companies Novartis (through its generic division, Sandoz) and Apotex announced that they were recalli...
Source: Harvard Health Blog - September 28, 2019 Category: Consumer Health News Authors: Joshua Gagne, PharmD, ScD Tags: Digestive Disorders Drugs and Supplements Health Source Type: blogs

Breathtaking: The Future Of Respiratory Care And Pulmonology
Smoke-measuring smart shirts, breath sound analyzing algorithms, and smart inhalers pave the way of pulmonology and respiratory care into the future. As the number of patients suffering from asthma, COPD, or lung cancer due to rising air pollution and steady smoker-levels will unfortunately not decrease any time soon, we looked around what technology can do to help both patients and caregivers. The results are breathtaking. Attacks of breathlessness are too common The diseases which pulmonologists and respiratory care specialists attempt to fight are among the most common conditions in the modern world – and the n...
Source: The Medical Futurist - September 25, 2019 Category: Information Technology Authors: nora Tags: Artificial Intelligence Future of Medicine Health Sensors & Trackers AI asthma cancer cancer treatment care COPD diagnostics inhaler lung lung cancer management medical specialty pulmonology respiratory respiratory care Source Type: blogs

Common hormonal treatments linked to abnormal heart rhythms and sudden death in men being treated for prostate cancer
Treatments for advanced prostate cancer that suppress testosterone, a hormone (also called an androgen) that drives the malignant cells to grow and spread, are collectively referred to as androgen deprivation therapies, or ADT. These therapies can significantly extend lifespans in men who have the disease, but they also have a range of challenging side effects. In 2004, Dr. Marc Garnick, Gorman Brothers Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, and editor in chief of HarvardProstateKnowledge.org, reported that in some men, an ADT drug called aberelix lengthens the time it tak...
Source: Harvard Health Blog - September 20, 2019 Category: Consumer Health News Authors: Charlie Schmidt Tags: Health Living With Prostate Cancer Men's Health Prostate Health Prostate Knowledge Treatments HPK Source Type: blogs

Fight Aging! Newsletter, September 9th 2019
We examined human lung tissue from COPD patients and normal control subjects, and found a substantial increase in p16-expressing alveolar cells in COPD patients. Using a transgenic mouse deficient for p16, we demonstrated that lungs of mice lacking p16 were structurally and functionally resistant to CS-induced emphysema due to activation of IGF1/Akt regenerative and protective signaling. Fat Tissue Surrounds Skeletal Muscle to Accelerate Atrophy in Aging and Obesity https://www.fightaging.org/archives/2019/09/fat-tissue-surrounds-skeletal-muscle-to-accelerate-atrophy-in-aging-and-obesity/ Researchers her...
Source: Fight Aging! - September 8, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

TAME Trial for the Effects of Metformin in Humans to Proceed this Year
Researchers and advocates have been trying for some years to launch the TAME trial to assess the effects of metformin on aging in humans. This is not with the hope of producing meaningful effects on the progression of aging. Metformin has a small effect size, being one of the less effective interventions that upregulates cellular stress responses, a strategy that in and of itself is weak in long-lived species such as our own. The goal is to push the FDA into accepting clinical trials that target mechanisms of aging rather than a specific named age-related condition. Metformin was chosen because its safety profile, widespre...
Source: Fight Aging! - September 6, 2019 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

Everyone Is Having the Wrong Healthcare Debate
By STEVEN MERAHN, MD In 1807, in an effort to spite the British and French for shipping interference (and forced recruitment of American citizens into military service), the United States Congress passed an Embargo Act, effectively shutting down trade with these two countries. Britain and France quickly found other trading partners; the US, then limited in our capacity to sell products outside our borders, was left with a devastated economy and a gaping hole in our face. It took only weeks before Congress passed a loophole; they repealed the act within 15 months of its passing. It was a great lesson in unintended co...
Source: The Health Care Blog - August 16, 2019 Category: Consumer Health News Authors: Christina Liu Tags: Health Policy Politics Uncategorized Health care debate Health Care Reform Steven Merahn universal healthcare Source Type: blogs

Virtual Bodies For Real Drugs: In Silico Clinical Trials Are The Future
Traditional clinical trials are equivalent of billions of dollars and years of hard work with no guarantee for the new drug to be approved by regulatory bodies, not to speak about the dangers of testing medication on animals and/or humans. What if we could take a radical turn? What if we conducted clinical trials on virtual bodies that could perfectly mimic human physiology? With the help of artificial intelligence, enhanced computer simulations, and advances in personalized medicine, in silico trials might be a reality in the coming years. The magic expression is in silico As technologies transform every aspect of h...
Source: The Medical Futurist - August 10, 2019 Category: Information Technology Authors: nora Tags: Future of Medicine Future of Pharma Personalized Medicine AI artificial intelligence clinical clinical trial clinical trials digital drug drugs in silico in silico trials Innovation medication simulation virtual Source Type: blogs

Why Don ’t Digital Health Investors Finance Solutions To Tough Medical Issues?
Why did activity trackers flood the digital health market, while there’s barely a company dealing with menopause, arthritis, or rare diseases? How do digital health investors decide when it comes to funding a new project, and what are the specific factors to take into account in relation to the healthcare market? We looked around what could scare off financiers from funding tough medical issues, and have a suggestion on how to bring forward solutions for marginalized health problems. Read on. Investment in digital health for everyone? Investment in healthcare, especially in the digital health market, is growing ste...
Source: The Medical Futurist - August 3, 2019 Category: Information Technology Authors: nora Tags: Business Future of Medicine companies company digital digital health digital health startups finance funding Healthcare investment technology Source Type: blogs

Why Don ’t Digital Health Investors Finance Tough Medical Issues?
Why did activity trackers flood the digital health market, while there’s barely a company dealing with menopause, arthritis, or rare diseases? How do digital health investors decide when it comes to funding a new project, and what are the specific factors to take into account in relation to the healthcare market? We looked around what could scare off financiers from funding tough medical issues, and have a suggestion on how to bring forward solutions for marginalized health problems. Read on. Investment in digital health for everyone? Investment in healthcare, especially in the digital health market, is growing ste...
Source: The Medical Futurist - August 3, 2019 Category: Information Technology Authors: nora Tags: Business Future of Medicine companies company digital digital health digital health startups finance funding Healthcare investment technology Source Type: blogs

Where, oh where, art thou, Arabinoxylan?
I hate to admit it, but there actually is something good in wheat and grains but it’s not B vitamins, cellulose fiber, or the approving looks of your doctor or dietitian. It’s arabinoxylan, as well as amylose, the prebiotic fibers of wheat/grains that nourish microorganisms in the gastrointestinal tract. It’s ironic that all the fuss about fiber intake that was the big push for bran cereals is not the form of fiber that yields genuine benefits, at least anything beyond bulking up bowel movements. It’s the neglected prebiotic fibers like arabinoxylan that were the source of any health benefits. The a...
Source: Wheat Belly Blog - May 29, 2019 Category: Cardiology Authors: Dr. Davis Tags: Wheat Belly Lifestyle bowel flora fiber gluten grains microbiota resistant starch Source Type: blogs

Fight Aging! Newsletter, May 20th 2019
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - May 19, 2019 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Still Negative on Watchman
Many readers have contacted me to ask whether my negative viewson left atrial appendage occlusion with Watchman have changed since 2017.   The short answer is no. My views are even more negative today.  In 2016, I published an editorial on theHeart.org | Medscape Cardiology arguing that this procedure should stop. One of the rebuttals was that it was a blog post, not an academic editorial. Months later, Andrew Foy, Gerald Naccarelli and I put the same argument into academic-speak and the influential journal Heart Rhythm published it.[1] I have debated and presented this topic multiple times ...
Source: Dr John M - May 17, 2019 Category: Cardiology Authors: Dr John Source Type: blogs